Nikhilesh R Mazumder1, Stela Celaj2, Kofi Atiemo3, Amna Daud3, Kathryn L Jackson4, Abel Kho4, Josh Levitsky5, Daniela P Ladner6. 1. Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL. 2. Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Northwestern University Transplant Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Feinberg School of Medicine, Northwestern University, Chicago, IL. 4. Center for Health Information Partnerships, Institute for Public Health and Medicine, Chicago, IL. 5. Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL; Northwestern University Transplant Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Feinberg School of Medicine, Northwestern University, Chicago, IL. 6. Northwestern University Transplant Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Feinberg School of Medicine, Northwestern University, Chicago, IL; Center for Healthcare Studies, Institute for Public Health and Medicine, Chicago, IL. Electronic address: dladner@nm.org.
Abstract
BACKGROUND & AIMS: Sex-based differences are known to significantly contribute to outcomes in patients with chronic liver diseases; however, the role of patient sex in cirrhosis is unclear. We aimed to study the relationship between patient sex and cirrhosis. METHODS: We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database that was linked with the United Network for Organ Sharing and cause of death data from the state death registry. Adjusted Cox survival analyses and competing risk analyses were performed to obtain subdistribution hazard ratios (HRs) for liver-related cause of death. RESULTS: Female and male patients had similar age, racial distribution, insurance status, and comorbidity status by Elixhauser score. Females had higher rates of cholestatic liver disease (17.1% vs. 6.2%, p <0.001) and non-alcoholic steatohepatitis (29.8% vs. 21.2%, p <0.001) than males. They were less likely to have portal hypertensive complications and had lower peak MELD-Na scores during follow-up. Female sex was associated with a decreased hazard of all-cause mortality (adjusted HR 0.85; 95% CI 0.80-0.90). This effect was attenuated when liver-related mortality was examined (subdistribution HR 0.93; 95% CI 0.87-1.00). No significant difference was noted for women who were 'ever-listed' in competing risk analyses for either all-cause mortality (subdistribution HR 1.09; 95% CI 0.88-1.35) or liver-related death (subdistribution HR 1.12; 95% CI 0.87-1.43), despite lower rates of listing (7.5% vs. 9.8%; p <0.001) and transplant (3.5% vs. 5.2%; p <0.001). CONCLUSIONS: In this longitudinal study of patients with cirrhosis, female sex was associated with a survival advantage likely driven by lower rates of non-liver-related death. Women were not at an increased risk of liver-related death despite lower rates of listing and transplantation. LAY SUMMARY: Patient sex is an important contributor in many chronic diseases, including cirrhosis. Prior studies have suggested that female sex is associated with worse outcomes. We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database. Using multivariate competing risk analyses, we found that female sex in cirrhosis is actually associated with a lower risk of all-cause mortality and has no association with liver-related mortality. Our findings are novel because we show that women with cirrhosis have a similar risk of liver-related death as their male counterparts, despite lower rates of listing and transplantation.
BACKGROUND & AIMS: Sex-based differences are known to significantly contribute to outcomes in patients with chronic liver diseases; however, the role of patient sex in cirrhosis is unclear. We aimed to study the relationship between patient sex and cirrhosis. METHODS: We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database that was linked with the United Network for Organ Sharing and cause of death data from the state death registry. Adjusted Cox survival analyses and competing risk analyses were performed to obtain subdistribution hazard ratios (HRs) for liver-related cause of death. RESULTS: Female and male patients had similar age, racial distribution, insurance status, and comorbidity status by Elixhauser score. Females had higher rates of cholestatic liver disease (17.1% vs. 6.2%, p <0.001) and non-alcoholic steatohepatitis (29.8% vs. 21.2%, p <0.001) than males. They were less likely to have portal hypertensive complications and had lower peak MELD-Na scores during follow-up. Female sex was associated with a decreased hazard of all-cause mortality (adjusted HR 0.85; 95% CI 0.80-0.90). This effect was attenuated when liver-related mortality was examined (subdistribution HR 0.93; 95% CI 0.87-1.00). No significant difference was noted for women who were 'ever-listed' in competing risk analyses for either all-cause mortality (subdistribution HR 1.09; 95% CI 0.88-1.35) or liver-related death (subdistribution HR 1.12; 95% CI 0.87-1.43), despite lower rates of listing (7.5% vs. 9.8%; p <0.001) and transplant (3.5% vs. 5.2%; p <0.001). CONCLUSIONS: In this longitudinal study of patients with cirrhosis, female sex was associated with a survival advantage likely driven by lower rates of non-liver-related death. Women were not at an increased risk of liver-related death despite lower rates of listing and transplantation. LAY SUMMARY:Patient sex is an important contributor in many chronic diseases, including cirrhosis. Prior studies have suggested that female sex is associated with worse outcomes. We analyzed a cohort of 20,045 patients with cirrhosis using a Chicago-wide electronic health record database. Using multivariate competing risk analyses, we found that female sex in cirrhosis is actually associated with a lower risk of all-cause mortality and has no association with liver-related mortality. Our findings are novel because we show that women with cirrhosis have a similar risk of liver-related death as their male counterparts, despite lower rates of listing and transplantation.
Authors: Abel N Kho; John P Cashy; Kathryn L Jackson; Adam R Pah; Satyender Goel; Jörn Boehnke; John Eric Humphries; Scott Duke Kominers; Bala N Hota; Shannon A Sims; Bradley A Malin; Dustin D French; Theresa L Walunas; David O Meltzer; Erin O Kaleba; Roderick C Jones; William L Galanter Journal: J Am Med Inform Assoc Date: 2015-06-23 Impact factor: 4.497
Authors: K Atiemo; A Skaro; H Maddur; L Zhao; S Montag; L VanWagner; S Goel; A Kho; B Ho; R Kang; J L Holl; M M Abecassis; J Levitsky; D P Ladner Journal: Am J Transplant Date: 2017-04-04 Impact factor: 8.086
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: David S Goldberg; James D Lewis; Scott D Halpern; Mark G Weiner; Vincent Lo Re Journal: Pharmacoepidemiol Drug Saf Date: 2012-11-04 Impact factor: 2.890
Authors: Jessica B Rubin; Marie Sinclair; Robert S Rahimi; Elliot B Tapper; Jennifer C Lai Journal: World J Gastroenterol Date: 2019-02-28 Impact factor: 5.742
Authors: Franziska C Trudzinski; Rudolf A Jörres; Peter Alter; Julia Walter; Henrik Watz; Andrea Koch; Matthias John; Marek Lommatzsch; Claus F Vogelmeier; Hans-Ulrich Kauczor; Tobias Welte; Jürgen Behr; Amanda Tufman; Robert Bals; Felix J F Herth; Kathrin Kahnert Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996
Authors: Sven H Loosen; Hans H Bock; Martin Hellmich; Wolfram T Knoefel; Christian Trautwein; Verena Keitel; Johannes G Bode; Ulf P Neumann; Tom Luedde Journal: Dtsch Arztebl Int Date: 2021-07-26 Impact factor: 5.594
Authors: Marcus Robertson; Andy K H Lim; Ashley Bloom; William Chung; Andrew Tsoi; Elise Cannan; Ben Johnstone; Andrew Huynh; Tessa O'Halloran; Paul Gow; Peter Angus; Daryl Jones Journal: J Clin Med Date: 2021-12-01 Impact factor: 4.241